Suzhou Ribo Life Science Co. Ltd. Class H

Suzhou Ribo Life Science Co. Ltd. Class H's next confirmed earnings release is scheduled for March 25, 2027.

As of December 31, 2025, Suzhou Ribo Life Science Co. Ltd. Class H has 161.69M shares outstanding.

As of December 31, 2025, Suzhou Ribo Life Science Co. Ltd. Class H maintains a current ratio of 0.86, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

These figures are as of the close on October 22, 2026.

As of December 31, 2025, Suzhou Ribo Life Science Co. Ltd. Class H holds 452.66M in cash and equivalents against 612.17M in total debt, resulting in a net debt position of 128.73M. Total book value stands at -104.54M, with working capital of -93.88M providing operational flexibility.